Hemorrhagic Shock due to Internal Thoracic Artery Injury After Cardiopulmonary Resuscitation
Clinical Case Reports · 2026-04 · 14 (4)
DOI: 10.1002/ccr3.72504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 10.04.2026. Verfasst von Tatsuya Fujihara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology Shimane University Faculty of Medicine Japan. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Reanimation
Abstract (Originalsprache)
Internal thoracic artery injury can occur after cardiopulmonary resuscitation (CPR). Aggressive fluid resuscitation may mask additional bleeding sites in cases of hemorrhage‐induced cardiac arrest. Persistent hemodynamic instability after return of spontaneous circulation should prompt evaluation for CPR‐related hemorrhagic complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology Shimane University Faculty of Medicine Japan.
- Division of Emergency and Critical Care Department Shimane Prefectural Central Hospital Japan.
- Department of Digestive and General Surgery, Faculty of Medicine Shimane University Shimane Japan.
ORCID-Profile: Tatsuya Fujihara
Zitieren
APA
Fujihara, T., Horiguchi, A., Taniura, T., & Nikai, T. (2026). Hemorrhagic Shock due to Internal Thoracic Artery Injury After Cardiopulmonary Resuscitation. Clinical Case Reports, 14(4). https://doi.org/10.1002/ccr3.72504
Vancouver
Fujihara T, Horiguchi A, Taniura T, Nikai T. Hemorrhagic Shock due to Internal Thoracic Artery Injury After Cardiopulmonary Resuscitation. Clinical Case Reports. 2026;14(4). doi:10.1002/ccr3.72504
BibTeX
@article{Fujihara2026,
author = {Fujihara, Tatsuya and Horiguchi, Akiyo and Taniura, Takahito and Nikai, Tetsuro},
title = {Hemorrhagic Shock due to Internal Thoracic Artery Injury After Cardiopulmonary Resuscitation},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/ccr3.72504}
}
EUVIMED